Terenzio Ignoni
Chief Operating OfficerDr. Terenzio Ignoni, Pharm.D., was Senior Vice President of Technical Operations of Gain Therapeutics, Inc. from June 2022 until July 2026 and serves as its Chief Operating Officer since July 2026. Dr. Ignoni was Senior Vice President of Quality & CMC of Gain Therapeutics, Inc. from June 2021 to June 2022. He serves as Senior Vice President of Quality and CMC at Gain Therapeutics, Inc. since June 2021. He joined Gain Therapeutics, Inc. in June 2021. Dr. Ignoni served as Quality Manager at Gentium S.p.A since January 2007. From April 2005 to December 2006, as Quality Control Manager, he was in charge of the development and implementation of the Quality Control Department of Gentium SpA which was audited, approved and officially authorized by the Italian Regulatory Agency in February 2007. From September 2002 to March 2005, he was analytical development Manager at Zambon Group, facility of Almisano di Lonigo, Italy. From March 2001 to September 2002 he worked in the Quality Control of Biosearch Manufacturing, company specialized in the research, development and manufacturing of antibiotics and antifungal agents. Mr. Ignoni received a Degree in Pharmaceutical chemistry and technologies at the University of Turin, Italy. He is also certified Qualified Person according to EU Directive 2001/83/EC and related amendment.
Positions
- Company NameGain Therapeutics, Inc.Stock CodeGANXPositionChief Operating Officer
